Ads
related to: soliris- Mechanism of Action
Learn about the MOA
of a new treatment option
- Dosing & Administration
Learn about dosing and
administration now
- Mechanism of Action
Search results
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters via AOL· 5 days agoAmgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex...
FDA Approves First Interchangeable Biosimilar for Two Rare Diseases
WLNS Lansing· 5 days agoToday, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat certain rare diseases ...
Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris
RTT News· 4 days agoThe U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British ...
FDA approves Amgen’s interchangeable biosimilar Bkemv
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe US Food and Drug Administration (FDA) has approved Amgen's Bkemv (eculizumab-aeeb) as the first...
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Benzinga via Yahoo Finance· 4 days agoTuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first...
This Pharma Stock Is Poised to Keep Outperforming the S&P 500 | The Motley Fool
The Motley Fool· 4 days agoAstraZeneca (AZN 1.23%), recognized as the world's sixth-largest pharmaceutical entity by market...
FDA approves interchangeable biosimilar to Soliris
Becker’s Hospital Review· 5 days agoThe FDA has approved Bkemv as the first interchangeable biosimilar to Soliris to treat certain rare diseases. Bkemv is approved for the treatment of patients with paroxysmal ...
Amgen’s rare-disease treatment biosimilar Bkemv gets FDA approval
Market Watch· 5 days agoPharmaceutical regulators approved Amgen’s Bkemv, a biosimilar to rare-disease treatment Soliris.
Should you buy Amgen’s stock above $300? | Invezz
Invezz· 2 days ago(NASDAQ:AMGN) has recently been in the news due to its involvement in the promising obesity drug market. The U.S. FDA has approved Amgen’s Bkemv, the...
NIH Scandal Grows; Ancient Skull Shows Brain Surgery; Drugs in New York's Rivers
MedPage Today· 5 days agoHealth news and commentary gathered by MedPage Today staff
Ads
related to: soliris
